We are live on ! Find out more
JG

Joel Greenblatt Gotham Asset Management

AUM $43B
1-Year Est. Return 34.97%
 

Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.

This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+34.97%
3 Year Est. Return
+97.97%
5 Year Est. Return
+117.45%
10 Year Est. Return
+441.95%
AUM
$2.36B
AUM Growth
+$118M
Cap. Flow
-$39.7M
Cap. Flow %
-1.68%
Top 10 Hldgs %
13.17%
Holding
1,160
New
181
Increased
351
Reduced
440
Closed
178

Sector Composition

Rank Sector Weight
1 Technology 22.35%
2 Consumer Discretionary 14.2%
3 Industrials 13.49%
4 Healthcare 12.93%
5 Consumer Staples 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTCT icon
951
PTC Therapeutics
PTCT
$5.83B
$202K 0.01%
4,785
GPK icon
952
Graphic Packaging
GPK
$3.54B
$201K 0.01%
+11,099
New +$203K
SHOE
953
Shoe Station Group
SHOE
$420M
$201K 0.01%
+5,624
New +$182K
WKHS icon
954
Workhorse Group
WKHS
$35.3M
$185K 0.01%
+4
New +$148K
MWA icon
955
Mueller Water Products
MWA
$3.89B
$179K 0.01%
+12,405
New +$178K
AMCR icon
956
Amcor
AMCR
$22.5B
$175K 0.01%
3,059
-10,601
-78% -$631K
TELL
957
DELISTED
Tellurian Inc.
TELL
$167K 0.01%
35,832
-50,864
-59% -$156K
HLX icon
958
Helix Energy Solutions
HLX
$1.53B
$164K 0.01%
28,690
-7,557
-21% -$39.7K
CHRS icon
959
Coherus Oncology
CHRS
$219M
$161K 0.01%
11,621
+1,370
+13% +$19.4K
CIM
960
Chimera Investment
CIM
$964M
$153K 0.01%
+3,394
New +$141K
HBAN icon
961
Huntington Bancshares
HBAN
$34.4B
$151K 0.01%
+10,574
New +$162K
ANGI icon
962
Angi Inc
ANGI
$200M
$142K 0.01%
1,054
-45
-4% -$6.54K
ATOS icon
963
Atossa Therapeutics
ATOS
$25.3M
$141K 0.01%
+1,492
New +$79K
SENS icon
964
Senseonics Holdings Inc
SENS
$513M
$138K 0.01%
1,797
+11
+0.6% +$557
ATEN icon
965
A10 Networks
ATEN
$1.9B
$131K 0.01%
11,627
-1,049
-8% -$10.2K
ACB
966
Aurora Cannabis
ACB
$249M
$120K 0.01%
+1,329
New +$115K
CDE icon
967
Coeur Mining
CDE
$21.6B
$120K 0.01%
13,541
-25,373
-65% -$245K
IMGN
968
DELISTED
Immunogen Inc
IMGN
$110K ﹤0.01%
16,712
-49,328
-75% -$344K
AIV
969
Aimco
AIV
$381M
$109K ﹤0.01%
+16,193
New +$111K
GEO icon
970
The GEO Group
GEO
$4.31B
$109K ﹤0.01%
15,247
-22,106
-59% -$139K
PSEC icon
971
Prospect Capital
PSEC
$1.17B
$109K ﹤0.01%
+13,034
New +$109K
AMRX icon
972
Amneal Pharmaceuticals
AMRX
$6.24B
$107K ﹤0.01%
+20,929
New +$119K
HBM icon
973
Hudbay
HBM
$13.4B
$102K ﹤0.01%
+15,318
New +$115K
EQX icon
974
Equinox Gold
EQX
$15.8B
$95K ﹤0.01%
+13,634
New +$117K
VRN
975
DELISTED
Veren
VRN
$94K ﹤0.01%
20,662
-9,991
-33% -$41.9K

Similar funds

Joel Greenblatt's Q2 2021 Portfolio in Review

As of Q2 2021, Joel Greenblatt held 1,160 positions worth $2.36B, up 5.3% from $2.24B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Joel Greenblatt's Q2 2021 filing shows 181 new, 351 increased, 440 reduced and 178 closed positions. Its largest new stake was Vertex Pharmaceuticals: 36,305 shares worth $7.32M. The largest sale was eBay, an estimated $8.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Joel Greenblatt's largest Q2 2021 buy was Vertex Pharmaceuticals: 36,305 shares worth $7.32M.
  • Joel Greenblatt added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $25.9M increase.
  • Joel Greenblatt's biggest Q2 2021 reduction was eBay, cutting an estimated $8.9M.
  • Joel Greenblatt fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $6.35M.
  • Joel Greenblatt's ten largest holdings make up 13% of its $2.36B portfolio in Q2 2021.
  • Joel Greenblatt opened 181 new positions and closed 178 in Q2 2021.
  • Joel Greenblatt's portfolio value rose 5.3% quarter-over-quarter to $2.36B.

Based on Gotham Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.